V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310005291 | 310002434 | 1.73 | null | Palliative (P) | 2015-06-24 | 2015-06-26 | Cabazitaxel | 2 | N | 310007288 | ETOPOSIDE |
| 310005292 | 310002434 | 1.82 | 99.7 | Curative (C) | 2014-12-23 | 2014-12-24 | IRINOTECAN + TEMOZOLOMIDE | N | N | 310007288 | GEMCITABINE + VINORELBINE |
| 310005293 | 310002434 | 1.73 | 81.8 | Curative (C) | 2016-10-23 | 2017-05-05 | Carboplatin + Vinorelbine IV | N | N | 310007288 | PEG INTERFERON |
| 310005294 | 310002434 | 1.69 | 83.4 | Palliative (P) | 2013-07-02 | 2013-07-02 | Capecitabine (21days) + Carboplatin | 01 | null | 310007288 | CARBOPLATIN + RT |
| 310005295 | 310002434 | 1.68 | 69 | Curative (C) | 2014-09-24 | 2014-09-24 | Methotrexate High Dose (3g/m2) | N | null | 310007288 | BRENTUXIMAB |
| 310005296 | 310002435 | 1.73 | 91.3 | Neo-adjuvant (N) | 2015-04-20 | 2015-04-21 | Cytarabine Low Dose | N | N | 310007819 | CYTARABINE |
| 310005297 | 310002436 | null | 63.2 | Palliative (P) | 2016-08-18 | 2016-09-03 | RCEOP | N | N | 310007855 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310005298 | 310002436 | 1.6 | 99.2 | Palliative (P) | 2014-08-01 | 2014-08-02 | Azacitidine | N | N | 310007855 | CARBOPLATIN + PEMETREXED |
| 310005299 | 310002437 | 1.65 | null | Curative (C) | 2016-01-23 | 2016-01-30 | IVE | N | N | 310008085 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310005300 | 310002438 | 1.85 | 85.3 | Neo-adjuvant (N) | 2013-06-15 | 2013-09-14 | Cyclophosphamide oral | 02 | N | 310008220 | CARBO + FLUOROURACIL |
| 310005301 | 310002438 | null | null | Curative (C) | 2017-06-19 | 2017-09-12 | Doxorubicin + Ifosfamide | 2 | N | 310008220 | CYCLOPHOSPHAMIDE |
| 310005302 | 310002438 | 1.6 | 66.6 | Palliative (P) | 2015-11-20 | 2015-12-19 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 310008220 | IRINOTECAN + MDG |
| 310005303 | 310002439 | 1.68 | 47.65 | null | 2016-02-05 | 2016-02-15 | CVP | N | N | 310008682 | CARBOPLATIN + VINORELBINE |
| 310005304 | 310002440 | null | 41.8 | Curative (C) | 2016-03-18 | 2016-04-02 | VINCRISTINE | N | Y | 310008787 | FEC |
| 310005305 | 310002440 | null | 98 | Curative (C) | null | 2018-01-10 | CMV | 2 | N | 310008787 | POUT TRIAL |
| 310005306 | 310002441 | 1.68 | 52.5 | Adjuvant (A) | 2016-09-04 | 2016-09-07 | Methotrexate 10mg/m2 po 7day | N | N | 310009232 | SUNITINIB |
| 310005307 | 310002442 | 1.75 | 63 | Curative (C) | 2016-06-02 | 2016-06-24 | DABRAFENIB | 2 | N | 310009263 | VIDE |
| 310005308 | 310002443 | null | null | Palliative (P) | 2015-11-09 | 2015-11-09 | OXALIPLATIN | 02 | N | 310009286 | CISPLATIN + PEMETREXED |
| 310005309 | 310002444 | 1.67 | 68.8 | Disease modification (D) | 2016-09-09 | 2016-09-24 | Alemtuzumab(INTRAVENOUS) | null | null | 310009562 | BEVACIZUMAB |
| 310005310 | 310002445 | null | 96.4 | Curative (C) | 2015-07-07 | 2015-07-08 | CYCLOPHOSPHAMIDE + ETOPOSIDE + VINCRISTINE | 02 | Y | 310009636 | UKALL2011 |
| 310005311 | 310007010 | 1.8 | 0 | Palliative (P) | 2015-12-07 | 2015-12-09 | POUT TRIAL | 02 | N | 310009727 | R-EPOCH |
| 310005312 | 310007010 | 1.62 | 95 | Palliative (P) | 2014-11-27 | 2014-11-27 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 310009727 | FEC |
| 310005313 | 310007010 | 1.69 | 61 | Disease modification (D) | 2017-08-30 | 2017-09-03 | Epirubicin (weekly) | 02 | null | 310009727 | FEC |
| 310005314 | 310002446 | 1.87 | 109 | Palliative (P) | 2019-06-05 | 2019-06-05 | Cisplatin + Dacarbazine | N | N | 310010400 | CISPLATIN + FLUOROURACIL + RT |
| 310005315 | 310002446 | 1.79 | 62.1 | Disease modification (D) | 2016-07-02 | 2016-07-23 | Capecitabine + Streptozocin | 01 | N | 310010400 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA |
| 310005316 | 310002447 | 1.65 | 95 | Curative (C) | 2018-09-23 | 2018-09-24 | DABRAFENIB | N | N | 310010646 | BEVACIZUMAB |
| 310005317 | 310007012 | 1.71 | null | Disease modification (D) | 2014-02-06 | 2014-03-07 | CVP R + GEMCITABINE | 02 | N | 310010710 | PMITCEBO-R |
| 310005318 | 310009270 | null | 76.1 | Curative (C) | 2016-09-09 | 2016-09-10 | Bevacizumab 7.5mg/kg | N | N | 310010718 | CAPECITABINE + CARBOPLATIN |
| 310005319 | 310002448 | null | 60 | Palliative (P) | 2015-05-03 | 2015-05-16 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE | null | N | 310010912 | FEC + DOCETAXEL |
| 310005320 | 310002449 | 1.57 | 54 | Curative (C) | 2015-02-16 | 2015-02-18 | Bevacizumab + Paclitaxel | 02 | N | 310010923 | FEC |
| 310005321 | 310002449 | 1.82 | 87 | Disease modification (D) | 2015-04-30 | 2015-05-01 | CVP R | 02 | N | 310010923 | EURO-EWING |
| 310005322 | 310002450 | 1.73 | 145 | Curative (C) | 2016-06-13 | 2016-06-15 | DABRAFENIB | N | N | 310011108 | IVE |
| 310005323 | 310002450 | 1.64 | null | Palliative (P) | 2017-06-08 | 2017-06-19 | IVE | 02 | N | 310011108 | DOCETAXEL + GEMCITABINE |
| 310005324 | 310002451 | 1.74 | 70.4 | null | 2015-07-25 | 2015-07-29 | CYCLO + RITUXIMAB + VINCRISTINE | 1 | N | 310011142 | CETUXIMAB |
| 310005325 | 310002452 | 1.83 | null | Disease modification (D) | 2015-05-23 | 2015-05-23 | IVE | 02 | N | 310011231 | DABRAFENIB + TRAMETINIB |
| 310005326 | 310002452 | 1.6 | null | Curative (C) | 2016-10-19 | 2016-10-19 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | 310011231 | METHOTREXATE INTRATHECAL |
| 310005327 | 310002452 | 1.67 | 67.2 | null | 2016-06-18 | 2016-06-25 | CVP R | N | N | 310011231 | CARBOPLATIN + RT |
| 310005328 | 310002452 | null | 79.4 | Curative (C) | 2014-11-12 | 2014-11-28 | ABVD | 02 | Y | 310011231 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 310005329 | 310011103 | 1.58 | 96 | Palliative (P) | 2013-12-11 | 2013-12-12 | FEC 60 or 75 | 02 | null | 310011498 | DABRAFENIB |
| 310005330 | 310011103 | null | 106 | Disease modification (D) | 2017-09-09 | 2017-09-18 | EW EuroEwing 99 : VIDE | N | N | 310011498 | CVP R |
| 310005331 | 310002453 | 1.72 | 76.4 | Disease modification (D) | 2016-04-21 | 2016-04-22 | Doxorubicin + Ifosfamide | N | N | 310011621 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 310005332 | 310002453 | 0 | 85 | Curative (C) | null | 2014-09-07 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 310011621 | AC |
| 310005333 | 310002454 | 1.5 | 61.4 | Palliative (P) | 2016-02-05 | 2016-11-04 | BEVACIZUMAB + CARBO | 2 | N | 310011788 | OCTREOTIDE |
| 310005334 | 310002455 | 1.65 | 76.4 | Palliative (P) | 2014-03-21 | 2014-04-04 | IVE | 2 | N | 310011811 | BENDAMUSTINE + RITUXIMAB |
| 310005335 | 310002456 | 1.67 | 61.4 | Palliative (P) | 2018-04-08 | 2018-04-09 | Temozolomide 200mg/m2 | N | 2 | 310011812 | CARBOPLATIN + VINORELBINE |
| 310005336 | 310007017 | 1.58 | 96 | Curative (C) | 2018-08-17 | 2018-08-19 | Alemtuzumab | N | N | 310011898 | ICE-R |
| 310005337 | 310002457 | 1.33 | 64.4 | Curative (C) | 2014-05-16 | 2014-06-06 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE | 2 | N | 310011899 | CISPLATIN + FLUOROURACIL + RT |
| 310005338 | 310007018 | null | 68.7 | Curative (C) | 2015-09-22 | 2015-09-30 | IDARAM | N | N | 310012026 | PAZOPANIB |
| 310005339 | 310007018 | 1.66 | 52 | Palliative (P) | 2017-04-26 | 2017-04-30 | Doxorubicin + Olaratumab | null | Y | 310012026 | DABRAFENIB |
| 310005340 | 310007018 | 1.75 | 79.7 | null | 2013-11-05 | 2013-11-20 | VAC | 02 | N | 310012026 | CARBO + FLUOROURACIL |